BRISBANE, Calif.--(BUSINESS WIRE)--XDx, Inc., a molecular diagnostics company focused on noninvasive gene expression tests for the monitoring of immune-mediated conditions, today announced that Pierre Cassigneul, president and chief executive officer, is scheduled to present at the JMP Securities Healthcare Focus Conference on Monday, October 5, 2009 at 3:00 p.m. (EDT) at the Palace Hotel in New York City.
